• 1
    Kessler TM, Burkhard FC, Perimenis P et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol 2004; 172: 13237
  • 2
    Schoenberg MP, Walsh PC, Breazeale DR, Marshall FF, Mostwin JL, Brendler CB. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup. J Urol 1996; 155: 4904
  • 3
    Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002; 167: 12958
  • 4
    Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 66675
  • 5
    Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 2004; 171: 64651
  • 6
    Ruffion A, Manel A, Massoud W et al. Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. Urology 2005; 65: 7037
  • 7
    Esrig D, Freeman JA, Elmajian DA et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 1996; 156: 10716
  • 8
    Pettus JA, Al-Ahmadie H, Barocas DA et al. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol 2008; 53: 3705
  • 9
    Schellhammer PF, Bean MA, Whitmore WF Jr. Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis. J Urol 1977; 118: 399403
  • 10
    Wood DP Jr, Montie JE, Pontes JE, VanderBrug Medendorp S, Levin HS. Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. J Urol 1989; 141: 3469
  • 11
    Scardino PT, Weaver R, Hudson MA. Early detection of prostate cancer. Hum Pathol 1992; 23: 21122
  • 12
    Mazzucchelli R, Barbisan F, Scarpelli M et al. Is incidental prostate cancer in patients undergoing radical cystoprostatectomy clinically significant? AJCP 2008 (in press)
  • 13
    Montironi R, Mazzucchelli R, Santinelli A, Scarpelli M, Lopez-Beltran A, Bostwick DG. Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens. Hum Pathol 2005; 36: 64654
  • 14
    Sobin LH, Wittekind Ch. Urologic tumours: prostate. In SobinLH, WittekindCh eds, TNM Classification of Malignant Tumours, 6th edn. New York: Wiley-Liss, 2002: 1847
  • 15
    Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL; ISUP, Grading Committee. The International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29: 122842
  • 16
    Helpap B, Egevad L. Correlation of modified Gleason grading with pT stage of prostatic carcinoma after radical prostatectomy. Anal Quant Cytol Histol 2008; 30: 17
  • 17
    Helpap B, Egevad L. Correlation of modified Gleason grading of prostate carcinoma with age, serum prostate specific antigen and tumor extent in needle biopsy specimens. Anal Quant Cytol Histol 2008; 30: 1338
  • 18
    Hofstädter F, Amin MB, Delahunt B et al. Tumours of the urethra. In EbleJN, SauterG, EpsteinJI, SesterhennIA eds, WHO Classification of Tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2004: 1547
  • 19
    Donat SM, Genega EM, Herr HW, Reuter VE. Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. J Urol 2001; 165: 111720
  • 20
    Scattoni V, Montironi R, Mazzucchelli R et al. Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg. BJU Int 2006; 98: 548
  • 21
    Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994; 271: 36874
  • 22
    Canda AE, Tuzel E, Mungan MU, Yorukoglu K, Kirkali Z. Conservative management of mucosal prostatic urethral involvement in patients with superficial transitional cell carcinoma of the bladder. Eur Urol 2004; 45: 4659
  • 23
    Kirkali Z, Canda AE. Superficial urothelial cancer in the prostatic urethra. Sci World J 2006; 6: 260310
  • 24
    Wolfe JH, Lloyd-Davies RW. The management of transitional cell carcinoma in the prostate. Br J Urol 1981; 53: 2537
  • 25
    Shen SS, Lerner SP, Muezzinoglu B, Truong LD, Amiel G, Wheeler TM. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol 2006; 37: 72634
  • 26
    Autorino R, Di Lorenzo G, Damiano R et al. Pathology of the prostate in radical cystectomy specimens: a critical review. Surg Oncol 2008; Epub ahead of print
  • 27
    Cindolo L, Benincasa G, Autorino R et al. Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: a retrospective study. Oncol Rep 2001; 8: 26971
  • 28
    Conrad S, Hautmann SH, Henke RP et al. Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients. Eur Urol 2001; 39: 259
  • 29
    Montie JE, Wood DP Jr, Pontes JE, Boyett JM, Levin HS. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer 1989; 63: 3815
  • 30
    Abbas F, Hochberg D, Civantos F, Soloway M. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Eur Urol 1996; 30: 3226
  • 31
    Moutzouris G, Barbatis C, Plastiras D et al. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder. Scand J Urol Nephrol 1999; 33: 2730
  • 32
    Lee SH, Chang PL, Chen SM et al. Synchronous primary carcinomas of the bladder and prostate. Asian J Androl 2006; 8: 3579
  • 33
    Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000; 85: 607
  • 34
    Chun TY. Coincidence of bladder and prostate cancer. J Urol 1997; 157: 657
  • 35
    Kurokawa K, Ito K, Yamamoto T et al. Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer. Urology 2004; 63: 26872
  • 36
    Liskow AS, Neugut AI, Benson M, Olsson CA, Birkhoff J, Chang CH. Multiple primary neoplasms in association with prostate cancer in black and white patients. Cancer 1987; 59: 3804
  • 37
    Sheldon CA, Williams RD, Fraley EE. Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J Urol 1980; 124: 62631
  • 38
    Singh A, Kinoshita Y, Rovito PM Jr et al. Higher than expected association of clinical prostate and bladder cancers. J Urol 2005; 173: 15269
  • 39
    Winkler MH, Livni N, Mannion EM, Hrouda D, Christmas T. Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens. BJU Int 2007; 99: 5548
  • 40
    Singh A, Jones RF, Friedman H et al. Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers. Anticancer Res 1999; 19: 54157
  • 41
    Amara N, Palapattu GS, Schrage M et al. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Cancer Res 2001; 61: 46605